CN104193827B - 一种丙型肝炎病毒第一高变区融合抗原及其应用 - Google Patents
一种丙型肝炎病毒第一高变区融合抗原及其应用 Download PDFInfo
- Publication number
- CN104193827B CN104193827B CN201410439852.0A CN201410439852A CN104193827B CN 104193827 B CN104193827 B CN 104193827B CN 201410439852 A CN201410439852 A CN 201410439852A CN 104193827 B CN104193827 B CN 104193827B
- Authority
- CN
- China
- Prior art keywords
- hvr1
- hepatitis
- antigen
- hcv
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410439852.0A CN104193827B (zh) | 2014-09-01 | 2014-09-01 | 一种丙型肝炎病毒第一高变区融合抗原及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410439852.0A CN104193827B (zh) | 2014-09-01 | 2014-09-01 | 一种丙型肝炎病毒第一高变区融合抗原及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104193827A CN104193827A (zh) | 2014-12-10 |
CN104193827B true CN104193827B (zh) | 2017-04-12 |
Family
ID=52079220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410439852.0A Active CN104193827B (zh) | 2014-09-01 | 2014-09-01 | 一种丙型肝炎病毒第一高变区融合抗原及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104193827B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432508B (zh) * | 2016-08-30 | 2017-12-05 | 深圳市伯劳特生物制品有限公司 | 一种pla2r‑thsd7a融合蛋白及其应用和试剂盒 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104710537A (zh) * | 2015-04-09 | 2015-06-17 | 汪运山 | 柯萨奇病毒ca16 vp1重组抗原及其单克隆抗体与应用 |
-
2014
- 2014-09-01 CN CN201410439852.0A patent/CN104193827B/zh active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106432508B (zh) * | 2016-08-30 | 2017-12-05 | 深圳市伯劳特生物制品有限公司 | 一种pla2r‑thsd7a融合蛋白及其应用和试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN104193827A (zh) | 2014-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100330278B1 (ko) | 간염c바이러스의타이핑방법및사용시약 | |
CN111693712A (zh) | 一种采用核酸适配体检测新冠病毒SARS-CoV-2 N蛋白的方法 | |
CN102121009B (zh) | 特异结合丙型肝炎病毒核心蛋白的核酸适体及其应用 | |
CN104650195B (zh) | Ev71病毒vp1重组抗原及其单克隆抗体与应用 | |
CN108473540B (zh) | 突变的hev多肽及其用于测定抗hev抗体的用途 | |
CN108912214B (zh) | 肠道病毒71型vp1抗原的免疫原性多肽及其制备方法与应用 | |
US20080138794A1 (en) | Method for detecting or measuring HBV | |
CN106885903A (zh) | 一种寨卡病毒e抗原及其在检测抗寨卡病毒抗体中的应用 | |
CN108196069A (zh) | 一种包含重组融合抗原a和b的丙型肝炎病毒抗体检测试剂及应用和重组融合抗原a和b | |
CN104193827B (zh) | 一种丙型肝炎病毒第一高变区融合抗原及其应用 | |
CN105254724B (zh) | 截短型丙型肝炎病毒hcv ns3抗原及其制备与应用 | |
Yousaf et al. | Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan | |
CA2539789A1 (en) | Peptide originating in hepatitis c virus | |
Chen et al. | The identification of a B-cell epitope in bovine viral diarrhea virus (BVDV) core protein based on a mimotope obtained from a phage-displayed peptide library | |
JP4615567B2 (ja) | C型肝炎ウイルス感染に関連する肝疾患の予後の予測 | |
Ali et al. | Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays | |
WO2006113522A2 (en) | Methods of detecting hepatitis c virus | |
Liang et al. | Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS | |
CN104710537A (zh) | 柯萨奇病毒ca16 vp1重组抗原及其单克隆抗体与应用 | |
CN108530521A (zh) | 重组丙型肝炎抗原的制备及应用 | |
Takao et al. | Antibody reactive to a hepatitis C virus (HCV)‐derived peptide capable of inducing HLA‐A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV‐infected individuals without HLA‐A2 restriction | |
CN107098980A (zh) | 一种检测风疹病毒抗体的融合蛋白及其制备方法 | |
Bian et al. | Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus | |
KR101949010B1 (ko) | 타깃 바이오마커에 고특이적이며 고선택적 결합이 가능한 펩타이드 유래 분자결합자를 이용한 뎅기바이러스 조기검출용 바이오칩 및 그 제조방법 | |
CN112225783A (zh) | Hcv重组抗原及其突变体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Wei Inventor after: Zhu Zhiwei Inventor after: Chen Zhen Inventor after: Ding Zhaoming Inventor after: Wang Yan Inventor after: Ou Lanxiang Inventor after: Wang Jiaying Inventor after: Kou Zongyang Inventor after: Ding Xinglong Inventor after: Wang Heng Inventor before: Chen Zhen Inventor before: Ding Zhaoming Inventor before: Wang Yan Inventor before: Ou Lanxiang Inventor before: Wang Jiaying Inventor before: Kou Zongyang Inventor before: Ding Xinglong Inventor before: Wang Heng Inventor before: Zhu Zhiwei |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant |